The combination of gonadotropin releasing hormone agonist and levonorgestrel-release intrauterine device/aromatase inhibitor for severe atypical hyperplasia and well-differentiated endometrial carcinoma
Yu, M.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.220
Date:
June, 2017
File:
PDF, 501 KB
english, 2017